Modern surgical antibiotic prophylaxis and therapy--less is more

Area of Science:

• Surgical Infectious Diseases
• Pharmacology
• Clinical Microbiology

Background:

• Adverse events from antibiotic use in surgery contribute significantly to patient morbidity and mortality.
• Surgical wound infection rates are influenced by patient condition, operative duration, and wound contamination.
• Evolving guidelines impact antibiotic prophylaxis for bacterial endocarditis, reducing necessity and dosage in some cases.

Purpose of the Study:

• To review current findings and recommendations on antibiotic use in surgical prophylaxis and therapy.
• To highlight the importance of appropriate antibiotic selection and administration timing.
• To emphasize the need for accurate diagnosis to guide antibiotic treatment and prevent resistance.

Main Methods:

• Review of recent findings and recommendations on surgical antibiotic use.
• Analysis of factors influencing surgical wound infection rates.
• Discussion of antibiotic selection criteria for prophylaxis and therapy.

Main Results:

• Adverse antibiotic events are a major cause of surgical morbidity and mortality.
• First- or second-generation cephalosporins are preferred prophylactic agents unless penicillin allergy exists.
• Single-dose antibiotic prophylaxis administered pre-incision is often effective; distinguishing infection, contamination, and inflammation is critical for appropriate treatment.

Conclusions:

• Optimizing antibiotic use in surgery requires careful consideration of risk factors, drug selection, and accurate diagnosis.
• Appropriate antibiotic prophylaxis and therapy can minimize adverse events and reduce the development of bacterial resistance.
• Stratifying patients by risk is essential for effective treatment and valid research interpretation.